Epstein Secrets

ordered a reduction Thursday in the 15-year, 8-month prison sentence of an Oakland man who talked online of planning to kill thousands of people in the Bay Area, saying the evidence failed to show Amer Alhaggagi was seriously planning or promoting terrorism." Alhaggagi, "a Berkeley High graduate, pleaded gu

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ordered a reduction Thursday in the 15-year, 8-month prison sentence of an Oakland man who talked online of planning to kill thousands of people in the Bay Area, saying the evidence failed to show Amer Alhaggagi was seriously planning or promoting terrorism." Alhaggagi, "a Berkeley High graduate, pleaded gui

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ordered a reduction Thursday in the 15-year, 8-month prison sentence of an Oakland man who talked online of planning to kill thousands of people in the Bay Area, saying the evidence failed to show Amer Alhaggagi was seriously planning or promoting terrorism." Alhaggagi, "a Berkeley High graduate, pleaded gu

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug